Insurance for unexpected expenses in case of complications during treatment and 48 months after treatment Coverage up to 200,000 USD


Dr.Hasan Mutlu (Clinical oncologist)– Best Costs, Reviews – Book Your Consultation
- Prof. Dr. Hasan Mutlu is a highly experienced clinical oncologist practicing at Medical Park Antalya Hospital Complex in Antalya, Turkey.
- Experience: Approximately 26 years in medical oncology.
- Main focus: Diagnosis and treatment of organ tumors, chemotherapy, targeted therapies, immunotherapy, genetic analysis, and complementary medicine in cancer care.
- Location: Medical Park Antalya Hospital Complex, Antalya, Türkiye.
Educational Background
- Medical school: Hacettepe University Faculty of Medicine, Turkey.
- Internal Medicine specialization: Akdeniz University Faculty of Medicine, Turkey (completed 1999).
- Advanced training: Internal Medicine and Medical Oncology specialization training in the USA through Akdeniz University (2013–2014).
- Academic title: Associate Professorship in Medical Oncology, Akdeniz University.
Professional Experience
- Current position: Clinical Oncologist at Medical Park Antalya Hospital Complex (since 2018).
- Previous roles:
- Oncologist at Lara Private Anadolu Hospital (2017–2018).
- Oncologist at Acıbadem Kayseri Hospital.
- Physician at Kayseri Training and Research Hospital (from 2009).
- Expertise: Diagnosis of organ-specific tumors, administering chemotherapy, and implementing targeted and immunotherapy treatments.
- Innovations: Engaged in next-generation genetic research and use of complementary medicine alongside standard cancer therapies.
Academic Contributions
- First author on over 30 original studies published internationally.
- Contributed to more than 100 domestic and international research articles.
- Participated in oncology teaching programs and scientific conferences.
Areas of Expertise
- Organ tumor treatment: Breast, lung, colon, stomach, liver, kidney, ovarian, esophageal, prostate, bladder, thyroid, and others.
- Chemotherapy: Standard and combination regimens for cancer management.
- Targeted therapies: Precision treatments aimed at specific cancer mutations.
- Immunotherapy: Stimulating the immune system to fight cancer cells.
- Genetic analysis: Next-generation sequencing to guide personalized treatment.
- Complementary medicine: Integrative approaches to support overall patient wellness during treatment.
Publications and Research
Prof. Dr. Hasan Mutlu has authored numerous research studies, including over 30 as the first author in international journals. His work includes:
- Clinical trials evaluating targeted therapies and immunotherapy in solid tumors.
- Genetic research aimed at identifying biomarkers for personalized cancer care.
- Studies on complementary medicine protocols improving patient quality of life during chemotherapy.
These publications underscore his active role in advancing modern oncology practices through research and evidence-based care.
Patient Care Philosophy
- Emphasizes clear communication and patient education at every stage of care.
- Adopts a holistic treatment approach combining standard oncology with complementary therapies.
- Supports international patients with online consultations and coordination of remote care.
- Focuses on cultural sensitivity and tailored care plans for diverse patient needs.
- Known for compassion and strong patient satisfaction in complex cases.
Professional Affiliations
- Member of relevant Turkish oncology societies.
- Certified clinical oncologist in Turkey.
- Participates in international oncology conferences and collaborates in research projects.
FAQs
- Is Dr. Hasan Mutlu board-certified?
- Yes. He holds certification in Internal Medicine and Medical Oncology in Turkey and holds the title of Associate Professor.
- What types of treatments does he provide?
- He administers chemotherapy, targeted therapies, immunotherapy, genetic profiling, and complementary medicine for various cancers.
- Does he treat international patients?
- Yes. He offers online consultations and assists with international patient coordination and care.
- What is the typical hospital stay?
- Most treatments are outpatient-based. Duration depends on the specific therapy plan.
- What languages does he speak?
- He is fluent in Turkish and English, facilitating effective communication with both local and international patients.
- How does he incorporate genetic testing?
- He uses next-generation genetic analysis to personalize and optimize treatment regimens.
- Does he follow complementary medicine approaches?
- Yes. He integrates evidence-based complementary therapies to support patient well-being during cancer treatment.
Patient reviews
Patient reviews









